A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

IsraelRecruitingPHASE2

Conditions

Myelodysplastic Syndromes · Cytopenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope National Medical Center, Duarte, California, United States
Contact: Study coordinator (Site Contact) · aartz@coh.org
Contact: Principal Investigator (Andrew Artz)
University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC), Miami, Florida, United States
Contact: Study coordinator (Site Contact) · msekeres@med.miami.edu
Contact: Principal Investigator (Mikkael Sekeres)
H. Lee Moffitt Cancer Center and Research Center, Tampa, Florida, United States
Contact: Study coordinator (Site Contact) · Rami.Komrokji@moffitt.org
Contact: Principal Investigator (Rami Komrokji)
Karmanos Cancer Institute at Mclaren Greater Lansing, Lansing, Michigan, United States
University of Pittsburgh Medical Health Center, Pittsburgh, Pennsylvania, United States
Border Medical Oncology Research, Albury, New South Wales, Australia
Contact: Study coordinator (Site Contact) · APuliyayil@bordermedonc.com.au
Contact: Principal Investigator (Anish Puliyayil)
Tweed Hospital, Tweed Heads, New South Wales, Australia
Contact: Study coordinator (Site Contact) · Alejandro.ArbelaezAcevedo@health.nsw.gov.au
Contact: Principal Investigator (Alejandro Arbelaez)
Westmead Hospital, Westmead, New South Wales, Australia
Contact: Study coordinator (Site Contact) · john.kwan@health.nsw.gov.au
Contact: Principal Investigator (John Kwan)
Townsville University Hospital, Douglas, Queensland, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Contact: Study coordinator (Site Contact) · devendra.hiwase@sa.gov.au
Contact: Principal Investigator (Devendra Hiwase)
Flinders Medical Centre, Bedford Park, South Australia, Australia
Contact: Study coordinator (Site Contact) · david.ross@sa.gov.au
Contact: Principal Investigator (David Ross)
Boxhill Hospital, Box Hill, Victoria, Australia
Contact: Study coordinator (Site Contact) · t.teh@alfred.org.au
Contact: Principal Investigator (Tse-Chieh Teh)
University Hospital Geelong, Geelong, Victoria, Australia
Contact: Study coordinator (Site Contact) · HANNAH.ROSE@barwonhealth.org.au
Contact: Principal Investigator (Hannah Rose)
Austin Health, Heidelberg, Victoria, Australia
Contact: Study coordinator (Site Contact) · chun.fong@austin.org.au
Contact: Principal Investigator (Chun Yew Fong)
Royal Melbourne Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (Site Contact) · lynette.chee@mh.org.au
Contact: Principal Investigator (Lynette Chee)
St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia
Contact: Study coordinator (Site Contact) · shuhying.tan@svha.org.au
Contact: Principal Investigator (Shuhying Tan)
Ballarat Oncology & Haematology Service, Wendouree, Victoria, Australia
Fakultni nemocnice Brno, Brno, Czechia
Fakultni nemocnice Kralovske Vinohrady, Prague, Czechia
Contact: Study coordinator (Site Contact) · cerna@fnkv.cz
Contact: Principal Investigator (Olga Cerna)
Vseobecna Fakultni Nemocnice Praha, Prague, Czechia
CHU Angers - Hopital Hotel Dieu, Angers, France
Centre Hospitalier de la Region dAnnecy, Épagny, France
CHU de Nantes - Hotel Dieu, Nantes, France
Contact: Study coordinator (Site Contact) · alice.garnier@chu-nantes.fr
Contact: Principal Investigator (Alice Garnier)
CHU Nice - Hopital de l'Archet 1, Nice, France
Contact: Study coordinator (Site Contact) · cluzeau.t@chu-nice.fr
Contact: Principal Investigator (Thomas Cluzeau)
Hopital Saint-Louis, Paris, France
Contact: Study coordinator (Site Contact) · lionel.ades@aphp.fr
Contact: Principal Investigator (Lionel Ades)
CH Rene-Dubos, Pontoise, France
Contact: Study coordinator (Site Contact) · riad.benramdane@ght-novo.fr
Contact: Principal Investigator (Riad Benramdane)
CHU de Bordeaux - Hopital Haut-Leveque, Talence, France
Contact: Study coordinator (Site Contact) · sophie.dimicoli-salazar@chu-bordeaux.fr
Contact: Principal Investigator (Sophie Dimicoli Salazar)
Klinikum Bayreuth GmbH, Bayreuth, Germany
Contact: Study coordinator (Site Contact) · alexander.kiani@klinikum-bayreuth.de
Contact: Principal Investigator (Alexander Kiani)
Charite-Campus Benjamin Franklin, Berlin, Germany
Contact: Study coordinator (Site Contact) · kathrin.rieger@charite.de
Contact: Principal Investigator (Kathrin Rieger)
Praxis am Volkspark Berlin, Berlin, Germany
Contact: Study coordinator (Site Contact) · jp.habbel@praxis-am-volkspark-berlin.de
Contact: Principal Investigator (Jan-Piet Habbel)
University Hospital Bonn, Bonn, Germany
Contact: Study coordinator (Site Contact) · karin.mayer@ukbonn.de
Contact: Principal Investigator (Karin Mayer)
Marien Hospital Dusseldorf GMBH, Düsseldorf, Germany
Contact: Study coordinator (Site Contact) · aristoteles.giagounidis@vkkd-kliniken.de
Contact: Principal Investigator (Aristoteles Giagounidis)
Universitaetsklinikum Duesseldorf AoeR, Düsseldorf, Germany
Klinikum Esslingen GmbH, Esslingen am Neckar, Germany
Contact: Study coordinator (Site Contact) · s.wessendorf@klinikum-esslingen.de
Contact: Principal Investigator (Swen Wessendorf)
University Hospital Halle (Saale), Halle, Germany
Contact: Study coordinator (Site Contact) · haifa.al-ali@uk-halle.de
Contact: Principal Investigator (Haifa Al-Ali)
Universitaetsklinikum Leipzig AoeR, Leipzig, Germany
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, Germany
Contact: Study coordinator (Site Contact) · daniel.sasca@unimedizin-mainz.de
Contact: Principal Investigator (Daniel Sasca)
Universitaetsmedizin Rostock, Rostock, Germany
Sheba Medical Center - Sheba Fund for Health Services and Research, Ramat Gan, Israel
Contact: Study coordinator (Site Contact) · Drorit.Merkel@sheba.health.gov.il
Contact: Principal Investigator (Drorit Merkel)
Sourasky Medical Center - Infrastructure and Health Services Fund of the Tel Aviv Medical Center, Tel Aviv, Israel
Middlemore Hospital, Auckland, New Zealand
Hospital Universitario Central de Asturias, Barcelona, Spain
Contact: Study coordinator (Site Contact) · bernalmaria@uniovi.es
Contact: Principal Investigator (Teresa Bernal del Castillo)
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Contact: Study coordinator (Site Contact) · dvalcarcelct@vhio.net
Contact: Principal Investigator (David Valcarcel Ferreiras)
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain
Contact: Study coordinator (Site Contact) · marnan@iconcologia.net
Contact: Principal Investigator (Montserrat Arnan Sangerman)
Hospital Universitario de Salamanca, Salamanca, Spain
Contact: Study coordinator (Site Contact) · mdiezcampelo@usal.es
Contact: Principal Investigator (Maria Diez Campelo)
Hospital Universitario Virgen del Rocio, Seville, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
Contact: Study coordinator (Site Contact) · sanz_gui@gva.es
Contact: Principal Investigator (Guillermo Sanz Santillana)

Study leads

Study Director
Takeda

View source on ClinicalTrials.gov Contact study team (email)